It's the risk reward factor. You've got a GSA contract holder that submits to FDA audits, producing a kit that can save lives. The validation of the company's history gives them a low risk and extremely high reward. That's why a lot of us here have been touting the company. This is huge for governments that plan on getting ahead of the game before FDA approval hits. In reality it isn't about the stock it is about saving lives.
News 
Market Data 
Discover 
AI
